Haemonetics Corporation Expands Portfolio with Acquisition of Vivasure Medical Limited

Haemonetics Corporation has acquired Vivasure Medical Limited, known for its bioabsorbable patch technology for percutaneous vessel closure. The acquisition involves an upfront cash payment of €100 million and up to an additional €85 million in contingent consideration. Haemonetics aims to deliver increased value to physicians and hospitals with the newly acquired technology.